Stockscreener 앱 받기
64.09
0.17%
-0.11
시간 외 거래:
64.09
전일 마감가:
$64.20
열려 있는:
$64.2
하루 거래량:
416.14K
Relative Volume:
0.71
시가총액:
$3.50B
수익:
$1.28B
순이익/손실:
$-222.15M
주가수익비율:
-15.67
EPS:
-4.09
순현금흐름:
$145.52M
1주 성능:
+1.86%
1개월 성능:
+1.94%
6개월 성능:
+46.76%
1년 성능:
+29.40%
1일 변동 폭
$63.66
$64.41
1주일 범위
$62.45
$64.78
52주 변동 폭
$32.48
$65.57
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
LIVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
64.09 | 3.51B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
From Humanoid Robots to AI Seating: VivaNova Debuts "Active Health" Tech at imm cologne 2026 - GlobeNewswire Inc.
Understanding the Setup: (LIVN) and Scalable Risk - Stock Traders Daily
Autotransfusion System Market is expected to reach US$ 1,094.30 - openPR.com
Emerald Mutual Fund Advisers Trust Purchases 26,202 Shares of LivaNova PLC $LIVN - MarketBeat
Cardiac Pacemaker Market Covering Prime Factors - openPR.com
SG Americas Securities LLC Reduces Stake in LivaNova PLC $LIVN - MarketBeat
These 4 Measures Indicate That LivaNova (NASDAQ:LIVN) Is Using Debt Safely - 富途资讯
Extracorporeal Membrane Oxygenation (ECMO) Machines Market - openPR.com
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results - marketscreener.com
About Us | Oil & Gas JournalLivaNova to Announce Fourth-Quarter and Full-Year 2025 Results - FinancialContent
Should I buy LivaNova PLC (LIA) stock before earnings seasonEarnings Volatility Patterns & Small Investment Portfolio - bollywoodhelpline.com
Medical Implants Market Is Booming So Rapidly Growth by 2033 |Biotronik, Inc., Livanova Plc, NuVasive - openPR.com
Are Options Traders Betting on a Big Move in LivaNova Stock? - MSN
What risks investors should watch in LivaNova PLC stockEconomic Indicators Overview & Top Analyst Picks Available for Free - bollywoodhelpline.com
Wall Street Recap: Can LivaNova PLC maintain sales growth2025 Market Overview & Growth Oriented Trading Recommendations - baoquankhu1.vn
LivaNova (NASDAQ:LIVN) Stock Price Crosses Above 50 Day Moving AverageTime to Sell? - MarketBeat
Aug Chart Watch: Whats the fair value of LivaNova PLC stock2025 Growth vs Value & Reliable Breakout Stock Forecasts - baoquankhu1.vn
LivaNova Announces Chief Legal Officer Resignation and Succession - The Globe and Mail
LivaNova chief legal officer Michael Hutchinson resigns; search for successor begins By Investing.com - Investing.com South Africa
LivaNova chief legal officer Michael Hutchinson resigns; search for successor begins - Investing.com UK
Does LivaNova PLC have strong fundamentalsEarnings Risk Report & Free Weekly Chart Analysis and Trade Guides - bollywoodhelpline.com
Market Trends: Does LivaNova PLC have pricing powerInsider Selling & Weekly Watchlist of Top Performers - baoquankhu1.vn
Macro Review: Is LivaNova PLC stock attractive for income investorsPortfolio Performance Summary & High Accuracy Investment Entry Signals - Bộ Nội Vụ
Extracorporeal Membrane Oxygenation Machine Market Size to Hit USD 725.99 Million by 2033, Growing at a CAGR of 4.91% - GlobeNewswire Inc.
LivaNova PLC (LIVN) Stock Analysis: Exploring a 17% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
The Technical Signals Behind (LIVN) That Institutions Follow - Stock Traders Daily
LivaNova (LIVN) Is Up 6.2% After Fresh Analyst Optimism on Advanced Therapies PortfolioWhat's Changed - Sahm
Is LivaNova PLC stock a dividend growth opportunityPortfolio Gains Report & Growth Oriented Trade Recommendations - Улправда
Neurological Implants Market to Reach USD 12.39 Billion by 2031 | - openPR.com
Barclays Raises Price Target for LivaNova (LIVN) Amidst Consistent Ratings | LIVN Stock News - GuruFocus
Will LivaNova PLC (LIA) stock outperform value peers2025 Fundamental Recap & Safe Entry Point Identification - ulpravda.ru
Is LivaNova PLC stock a top momentum playQuarterly Profit Summary & Expert Curated Trade Setups - Улправда
Published on: 2026-01-08 23:06:55 - Улправда
Published on: 2026-01-08 21:18:32 - Улправда
Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 28%? - Yahoo Finance
The Brain: From Black Box To Engineering Problem - Seeking Alpha
Extracorporeal Membrane Oxygenation Machine Market - openPR.com
6 Analysts Assess LivaNova: What You Need To Know - Benzinga
Stifel raises Livanova stock price target to $70 on cardiopulmonary growth By Investing.com - Investing.com Canada
LIVN: Stifel Raises Price Target to $70, Maintains Buy Rating | - GuruFocus
LivaNova (NASDAQ:LIVN) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat
Stifel raises Livanova stock price target to $70 on cardiopulmonary growth - Investing.com Nigeria
In-Line Blood Monitoring Devices Market is expected to reach US$ - openPR.com
Market Fear: What is the fair value of LivaNova PLC stock nowTrade Risk Assessment & Fast Entry Momentum Alerts - moha.gov.vn
Electroceutical Devices Market to Reach USD 29,785.39 million - openPR.com
Published on: 2026-01-02 09:16:46 - moha.gov.vn
Precision Trading with Livanova Plc (LIVN) Risk Zones - Stock Traders Daily
LivaNova stock tests investor patience as Wall Street weighs turnaround against volatility - AD HOC NEWS
LivaNova CEO talks growth roadmap as company targets sleep apnea, depression therapies - MassDevice
LIVANOVA PLC (LIVN) - MSN
LivaNova PLC $LIVN Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Livanova Plc 주식 (LIVN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| PODLOGAR SUSAN M | Director |
Dec 15 '25 |
Option Exercise |
0.00 |
2,355 |
0 |
2,355 |
| Hutchinson Michael Damon | SVP, CLO and Company Secretary |
Dec 15 '25 |
Option Exercise |
0.00 |
2,254 |
0 |
7,920 |
| Story Brooke | Director |
Nov 18 '25 |
Sale |
53.94 |
250 |
13,485 |
6,232 |
2.37%
0.96%
자본화:
|
볼륨(24시간):